FibroBiologics, Inc. (FBLG)
0.3286
+0.05
(+16.15%)
USD |
NASDAQ |
Feb 27, 16:00
0.33
0.00 (0.00%)
Pre-Market: 20:00
FibroBiologics Shareholders Equity (Quarterly) : 6.156M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 327.19M |
| SELLAS Life Sciences Group, Inc. | 45.63M |
| Intelligent Bio Solutions, Inc. | 11.09M |
| iSpecimen, Inc. | 3.073M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.36M |
| Total Liabilities (Quarterly) | 13.21M |
| Debt to Equity Ratio | 0.3915 |
| Current Ratio | 3.609 |
| Net Debt Paydown Yield | -1.13% |